Dr. John Hanrahan, of the Cystic Fibrosis Translational Research Centre (CFTRc) from McGill University, appeared on CTV news to explain that a new treatment for the genetic disease is derived from...
Half of all CF patients in Canada do not live to see the age of 34, and these are the best results in the world. Treatment is complex, requiring a daily routine that includes consuming many pills...
David Thomas, professor and chair in the Department of Biochemistry at McGill University addresses progress in molecular biology and the latest strategies for tackling genetic disease. ...
A team of researchers at the Cystic Fibrosis Translational Research Centre at McGill University and the University of British Columbia (UBC) have uncovered a new molecule for the treatment of...
Gergely Lukacs, from the Department of Physiology, talks about cystic fibrosis, a paradigm of conformational diseases. A "Soup and Science" presentation....
Cystic fibrosis is caused by a mutation in the gene that encodes a particular protein, known as the cystic fibrosis transmembrane conductance regulator (or CFTR). Although this discovery was made...
For McGill scientists specializing in protein-traffi cking diseases such as cystic fi brosis (CF), October 17, 2011 marked a monumental event with the opening of McGill’s Cystic Fibrosis...
Once again the Cystic Fibrosis Translational Research Centre (CFTRc) team from McGill University participated in the annual Walk to Make Cystic Fibrosis History. As a nation, Canada raised $3...
RSS